EUVIMEDEUVIMED entdecken
Crossref

IDIC‐Based Phototheranostic Nanoparticles for NIR Light‐Excited Immuno‐Phototherapy

Yifei Hua, Xiaoli Chen, Lin Xu, Huan Li iD, Wenjie Gao, Ming Gao iD

Luminescence · 2025

DOI: 10.1002/bio.70343 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Luminescence, 2025. Verfasst von Yifei Hua und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China. Hauptthemen laut MEDLINE: Infrared Rays, Nanoparticles, Antineoplastic Agents, Immunotherapy. Die Arbeit nennt 26 Literaturangaben. Gefördert von: 2024 Jiangsu Provincial Graduate Research and Innovation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of single component, multifunctional phototheranostic platforms remains a crucial objective in precision cancer therapy. Here, we design near‐infrared (NIR) light‐activated nanoparticles (NPs) by assembling IDIC with DSPE‐PEG‐NH 2 to achieve high photothermal conversion efficiency, reactive oxygen species generation, and biocompatibility. The resulting IDIC NPs exhibit strong NIR absorption and fluorescence, high photostability, and good aqueous stability. Upon 635‐nm laser irradiation, they reach a photothermal conversion efficiency of 52.8% and a singlet oxygen quantum yield of 43.0%, enabling synergistic photothermal and photodynamic therapy. In vitro, IDIC NPs show negligible dark toxicity but induce potent tumor cell ablation upon irradiation through mitochondrial membrane disruption and immunogenic cell death, evidenced by calreticulin exposure, HMGB1 release, and ATP secretion. In vivo, they enable effective NIR imaging, inhibit tumor growth, prolong survival, and cause minimal systemic toxicity. Laser‐treated tumors exhibit enhanced apoptosis, reduced proliferation, and macrophage polarization toward an M1 phenotype. These findings establish IDIC NPs as a robust, single‐component nanotheranostic agent integrating NIR imaging, photothermal/photodynamic synergy, and immune activation for cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Infrared RaysNanoparticlesAntineoplastic AgentsImmunotherapyPhotosensitizing AgentsPhototherapyTheranostic NanomedicineAnimalsHumansMicePhotochemotherapyApoptosisCell ProliferationCell SurvivalParticle Size

Stichwörter der Autor:innen

IDICimmunogenic cell deathmitochondrial dysfunctionphotodynamic therapyphotothermal therapy

Substanzen

Antineoplastic AgentsPhotosensitizing Agents

Autor:innen und Institutionen

  • Department of Endocrinology, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Ultrasound, Sir Run Run Hospital, Nanjing Medical University, Nanjing, Jiangsu, China.
  • Department of Gastroenterology, Second Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Department of General surgery, Affiliated Hospital of Jiangsu University, Jiangsu University, Zhen Jiang, Jiangsu, China.

ORCID-Profile: Huan Li, Ming Gao

Förderung

  • 2024 Jiangsu Provincial Graduate Research and Innovation Program

Zitieren

APA

Hua, Y., Chen, X., Xu, L., Li, H., Gao, W., & Gao, M. (2025). IDIC‐Based Phototheranostic Nanoparticles for NIR Light‐Excited Immuno‐Phototherapy. Luminescence. https://doi.org/10.1002/bio.70343

Vancouver

Hua Y, Chen X, Xu L, Li H, Gao W, Gao M. IDIC‐Based Phototheranostic Nanoparticles for NIR Light‐Excited Immuno‐Phototherapy. Luminescence. 2025. doi:10.1002/bio.70343

BibTeX
@article{Hua2025,
  author = {Hua, Yifei and Chen, Xiaoli and Xu, Lin and Li, Huan and Gao, Wenjie and Gao, Ming},
  title = {IDIC‐Based Phototheranostic Nanoparticles for NIR Light‐Excited Immuno‐Phototherapy},
  journal = {Luminescence},
  year = {2025},
  doi = {10.1002/bio.70343}
}
Kostenlos starten →